Changes in serum lipoproteins were studied in 14 non-insulin dependent diabetics on long-term metformin therapy, after 6 weeks' placebo, and again 6 weeks after restarting active drug therapy. Withdrawal of metformin resulted in a rise of fasting blood glucose, HbAl, serum total and low density lipoprotein (LDL) cholesterol. Restarting the drug reversed these changes. Multivariate analysis showed that serum total and LDL cholesterol varied with treatment but not with glycaemic control Metformin can lower serum total and LDL cholesterol in non-insulin dependent diabetics and this effect is maintained long term.
PanzramG.Mortality and survival in Type 2 (non-insulin dependent) diabetes mellitus. Diabetologia1987; 30: 123–31
2.
LewisB.The lipoproteins: Predictors, protectors and pathogens. Br Med J1983; 287: 1161–4
3.
SeviourPWTealTKRichmondWRElkelesRS. Serum lipids, lipoproteins and macrovascular disease in non-insulin dependent diabetes – a possible new approach to prevention. Diabetic Med1988; 5: 166–71
4.
RainsSGHWilsonGARichmondWRElkelesRS. The effect of metformin and glibenclamide on serum lipids in non-insulin dependent diabetes. Diabetic Med1986; 3: 571A
5.
WarnickGRBendersonJAlbersJJ. Dextran sulphate-Mg2+ precipations procedure for quantitation of high density lipoprotein cholesterol. Clin Chem1982; 28: 1379–88
6.
FriedwaldWTLevyRIFredricksonDS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultra-centrifuge. Clin Chem1972; 18: 499–502
7.
AroAVoutilainenEPentikainenPUusitupaMPenttilaI.Effects of Metformin on serum and lipoprotein lipid levels. Diabetes Res Clin Pract1985; 1Suppl 1: Abstract 62
8.
SherwinRSTamborlaneWV. Metabolic control and diabetic complications. In OlefskyJMSherwinRS, eds. Diabetes mellitus: management and complications.New York: Churchill Livingstone, 1985: 1–29
